Stem Point Capital LP Revolution Medicines, Inc. Transaction History
Stem Point Capital LP
- $314 Billion
- Q1 2025
A detailed history of Stem Point Capital LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 318,782 shares of RVMD stock, worth $11.2 Million. This represents 3.59% of its overall portfolio holdings.
Number of Shares
318,782
Previous 193,535
64.72%
Holding current value
$11.2 Million
Previous $8.47 Billion
33.16%
% of portfolio
3.59%
Previous 2.11%
Shares
3 transactions
Others Institutions Holding RVMD
# of Institutions
312Shares Held
188MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$581 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$474 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$469 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$413 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$357 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.07B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...